AHA 2020: Lowering LDL cholesterol in older patients is beneficial
In patients aged ≥75 years, lipid-lowering was as effective in reducing cardiovascular events as...
Read More
Meeting Coverage
AHA 2020: Cardiovascular disease on outcomes among hospitalized COVID-19 patients
A study of nearly 30,000 COVID-19 patients revealed that cardiovascular disease or risk factors...
Read More
AHA 2020: No benefit from high-dose omega-3 for AF high-risk patients
A large randomized controlled trial comparing high-dose omega-3 with placebo corn oil did not find...
Read More
AHA 2020: Obese patients 50 years or younger have worse COVID-19 outcomes
Patients with a body mass index (BMI) of ≥40 had more than double the risk of being put on a...
Read More
AHA 2020: Finerenone lowers CV events in diabetic CKD patients
Finerenone treatment lowered the risk of chronic kidney disease (CKD) progression, as well as...
Read More
AHA 2020: Extra imaging for women with heart attacks without blockage
In a series of over 300 women who had a heart attack without any major artery blockages,...
Read More
AHA 2020: Children exposed to tobacco smoke have worse heart function as adults
Childhood passive smoke exposure, independent of whether the individual smokes themselves, was...
Read More
AHA 2020: Sotagliflozin shows cardiorenal benefits in diabetes patients: 2 trials
Although both trials ended early due to the COVID-19-related loss of funding, data from 2 large...
Read More
AHA 2020: AF screening benefit: the mHealth Screening to Prevent Strokes (mSTOPS) study
The 3-year results of the prospective mSTOPS study support the clinical value of early screening...
Read More
AHA 2020: PIONEER III trial: Drug-eluting stents are comparable
Among patients with acute and chronic coronary syndromes undergoing PCI, the new Supreme...
Read More
AHA 2020: Clever trial design gets patients back on statins: the SAMSON trial
Patients who had previously quit taking a statin due to side effects were randomized to...
Read MoreAHA: Finerenone Protects Patients with Kidney Disease and Diabetes
Cardiovascular outcomes reduced with new agent DALLAS — The novel selective mineralocorticoid receptor antagonist finerenone appears to protect at-risk patients from cardiovascular events when compared with placebo,...
Read MoreAHA: Silent CVD Common in ’Healthy’ People
Swedish population screening finds 40% have coronary artery disease DALLAS — If you can find a roomful of people in today’s Covid-19 restrictions, in addition to a greater risk of contracting the pandemic illness,...
Read MoreNews Coverage from AAO 2020: Teleophthalmology Effective & Prevents Unnecessary Office Visits During COVID-19
In order to understand the outcomes of a teleophtalmology intitiative implemented at the Columbia University Irving Medical Center during the COVID-19 pandemic, researchers analyzed the number of patients requiring in-office...
Read MoreNews Coverage from AAO 2020: Pilocarpine Promising for Presbyopia
Study results have long shown that miotics can help improve near vision by contracting the iris sphincter, thus reducing pupil size. Mild contraction of the ciliary muscle with some agents, including pilocarpine, may also...
Read MoreNews Coverage from AAO 2020: Real-World Outcomes With the Fluocinolone Acetonide Implant for Diabetic Macular Edema
Although data suggest that anti-vascular endothelial growth factor injections work well for most, but not all, patients with diabetic macular edema (DME), real-world evidence indicates that outcomes fall far short of those seen...
Read MoreNews Coverage from AAO 2020: Accurately Identifying Neovascular AMD at Home
Patients can use an optical coherence tomography (OCT) device at home to accurately identify retinal fluid caused by neovascular age-related macular degeneration (nAMD), researchers say . With the COVID-19 pandemic compounding...
Read MoreNews Coverage from AAO 2020: PACK-CXL Vs Antimicrobials for Early Infectious Corneal Ulcers
In order assess the time to corneal epithelization with photoactivated chromophore for infectious keratitis-corneal cross-linking (PACK-CXL) as a first-line treatment for early infectious corneal ulcers and to compare PACK-CXL...
Read More
ACAAI 2020: Immune System Shaped into Adolescence by Prenatal Dog Ownership
Prior research indicates an association between prenatal pet exposure and immunoglobulin E (IgE)...
Read More
ACAAI 2020: QOL Disproportionately Affected by Food Allergies in Asian Americans
An examination of 6,829 questionnaires completed by the parents of children with food allergies at...
Read More